Biological, genetic and lifestyle moderators of Alzheimer's pathogenesis, cognitive decline and clinical disease progression [ 2020 - ]

Research Grant

Researchers: Dr Yen Ying Lim (Principal investigator)

Brief description Alzheimer’s disease (AD) is the most common form of dementia, and the number of people living with it will triple by 2050. There is currently no cure for AD, and the only means of slow the growing epidemic is to delay onset. We propose to understand the complex interplay between genetic, cognitive, neuroimaging and biological markers of AD in order to better understand the disease process, and in turn identify high-risk individuals for clinical trials and uncover disease-modifying strategies.

Funding Amount $437,036.00

Funding Scheme Career Development Fellowships

Notes RD Wright Biomedical CDF